CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,092
- in 3 filings, $19K under 10b5-1 plans
Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-23 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −5,284 | 119,143 | ||
| 2018-10-26 | Hack Andrew A. F. Chief Financial Officer | Option exercise | +6,000 | $3.23 | $19K | 6,000 |
| 2018-10-26 | Hack Andrew A. F. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,000 | 124,427 |
Page 15 of 15 · 283 trades